TSLP, IL‐31, IL‐33 and sST 2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Recent years have seen growing interest in identifying new biomarkers in atopic dermatitis (AD) that could serve as indicators of disease severity and predictors of treatment response. Objectives: We compared serum levels of thymic stromal lymphopoietin (TSLP), interleukin(IL)‐31, IL‐33 and soluble(s)ST 2 in AD patients and healthy controls, investigated the possible correlation with disease severity, investigated if other atopic comorbidities could play a role, and assessed their potential as biomarkers in AD. Methods: Using standard enzyme‐linked immunosorbent assay techniques, we measured target serum levels in 71 adults and 61 children with AD, and 31 adult controls. We characterized our cohort by disease severity, radioallergosorbent test status concerning both dietary and inhalant allergens, and anamnestic reports of food allergy, concomitant allergic asthma and/or allergic rhinitis. Results: Serum levels of TSLP, IL‐31 and IL‐33, but not sST 2, were significantly elevated in AD patients compared with controls. In AD patients, both IL‐31 and IL‐33 serum levels were higher in children than in adults, while the opposite was the case for sST 2. We observed no correlation between disease severity and any of the investigated targets. While serum TSLP levels were unaffected by concomitant allergies and atopic comorbidities, serum levels of IL‐31, IL‐33 and sST 2 were affected to a small extent. We found a positive correlation between TSLP, IL‐31 and IL‐33, and an inverse relationship between IL‐33 and sST 2. Conclusions: The studied targets hold little potential as indicators of disease severity. The serum values of our targets show robustness against atopic comorbidities, allergies and changes in disease severity. This robustness strengthens their potential use in biomarker‐based stratification and could be instrumental in identifying subgroups and predicting the possible benefit of therapeutic and prevention approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic features of atopic dermatitis
Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086
Thymic stromal lymphopoietin: master switch for allergic inflammation
Liu, Y.-J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051745 · Cited by 576
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
Kim, B. E., Leung, D. Y. M., Boguniewicz, M., & Howell, M. D. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.11.006 · Cited by 538
Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis
van den Bogaard, E. H., Bergboer, J. G. M., Vonk-Bergers, M., van Vlijmen-Willems, I. M. J. J., Hato, S. V., van der Valk, P. G. M., Schröder, J. M., Joosten, I., Zeeuwen, P. L. J. M., & Schalkwijk, J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65642 · Cited by 373
Correlation of IL-31 serum levels with severity of atopic dermatitis
Raap, U., Wichmann, K., Bruder, M., Ständer, S., Wedi, B., Kapp, A., & Werfel, T. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.05.047 · Cited by 299
Atopic dermatitis: a candidate for disease‐modifying strategy
Bieber, T., Cork, M., & Reitamo, S. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02845.x · Cited by 131
Kim, J. H., Bae, H. C., Ko, N. Y., Lee, S. H., Jeong, S. H., Lee, H., Ryu, W.-I., Kye, Y. C., & Son, S. W. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.04.026 · Cited by 75
Cited by
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
Griesenauer, B., & Paczesny, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00475 · Cited by 619
Chu, D. K., Schneider, L., Asiniwasis, R. N., Boguniewicz, M., De Benedetto, A., Ellison, K., Frazier, W. T., Greenhawt, M., Huynh, J., Kim, E., et al. (2024) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2023.11.009 · Cited by 380
Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council
Renert-Yuval, Y., Thyssen, J. P., Bissonnette, R., Bieber, T., Kabashima, K., Hijnen, D., & Guttman-Yassky, E. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.01.013 · Cited by 350
Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go?
Bieber, T., D'Erme, A. M., Akdis, C. A., Traidl-Hoffmann, C., Lauener, R., Schäppi, G., & Schmid-Grendelmeier, P. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.008 · Cited by 330
Rerknimitr, P., Otsuka, A., Nakashima, C., & Kabashima, K. (2017) · Inflammation and Regeneration · doi:10.1186/s41232-017-0044-7 · Cited by 187
“It has been suggested that DCs initiate AD in humans, although it remains unclear which cutaneous DC subsets initiate epicutaneous sensitization.”
BackgroundInfluentialAssociation between Stress and the HPA Axis in the Atopic Dermatitis
Lin, T.-K., Zhong, L., & Santiago, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102131 · Cited by 127
Brunner, P. M., He, H., Pavel, A. B., Czarnowicki, T., Lefferdink, R., Erickson, T., Canter, T., Puar, N., Rangel, S. M., Malik, K., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.04.036 · Cited by 109
TSLP is a direct trigger for T cell migration in filaggrin-deficient skin equivalents
Wallmeyer, L., Dietert, K., Sochorová, M., Gruber, A. D., Kleuser, B., Vávrová, K., & Hedtrich, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-00670-2 · Cited by 82
Metadata
- Authors
- Nygaard, U., Hvid, M., Johansen, C., Buchner, M., Fölster‐Holst, R., Deleuran, M., & Vestergaard, C.
- Venue
- Journal of the European Academy of Dermatology and Venereology
- Publisher
- Wiley
- Published
- 2016-05-06
- Volume
- 30
- Issue
- 11
- Pages
- 1930-1938
- ISSN
- 0926-9959 (ISSN-L)
- 1468-3083
- OpenAlex
- W2346851822
- Cited by
- 157
- References
- 7
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.